SOL-O PAKE LIQUID E.Z. PAQUE

Dose: 0.57 to 2.14 mg/kg
Single Dose: 1.4 (1.355)
Frequency: As recommended.
Route: PO
Instructions: As Required

. It is of Synthetic origin and belongs to Barium Salt. It belongs to Radiopaque Agents pharmacological group on the basis of mechanism of action and also classified in Diagnostic Aids pharmacological group.The Molecular Weight of Barium Sulphate is 233.00.

Barium Sulphate is contraindicated in conditions like Tracheo-oesophageal fistula,Suspected intestinal perforation,Small bowel obstruction.

The severe or irreversible adverse effects of Barium Sulphate, which give rise to further complications include Bacteremia.The symptomatic adverse reactions produced by Barium Sulphate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Diarrhea, Constipation, Appendicitis.

Barium Sulphate is primarily indicated in conditions like Delineation of GI in ctexamination, Esophagus imaging, Ileostomy enema, Small bowel imaging, Stomach imaging.

No data regarding the interactions of Barium Sulphate was found.

Drug should not be given to Paediatrics, Pregnant Mothers, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Powder Store in a well closed container, Below 40°C. Protect from Moisture.

Barium sulfate should not be given to patients with intestinal obstruction and care is needed in those with condition which may predisposed to obstruction. Adequate hydration should be ensured to avoid constipation. Avoid in patients with gastrointestinal perforation, and should be avoided, particularly when given rectally. Aspiration may lead to Pneumonitis.